SEC Form 4 · accession 0001162194-15-000077

STANDARD BIOTOOLS INC. · LAB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, LEGAL AFFAIRS & GC

Period of report

Apr 17, 2015

Accepted (ET)

Apr 21, 2015 · 5:15 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001162194

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 17, 2015	M	3,000	$4.4461	A	3,922	D
Common Stock^F2	Apr 17, 2015	S	1,900	$42.64	D	2,022	D
Common Stock^F3	Apr 17, 2015	S	1,100	$43.77	D	922	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F4	$4.4461	Apr 17, 2015	M	3,000	D	—	Apr 23, 2018	Common Stock	3,000	1,503	D

F1The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2014.
F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $42.37 to $43.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $43.495 to $44.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4The shares subject to the Option fully vested on May 1, 2008.